EA
CBPO

Emerald Acquisition’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Emerald Acquisition’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$10.2M Sell
82,146
-34,488
-30% -$4.07M 0.02% 859
2016
Q2 		$12.4M Buy
+116,634
New +$13.5M 0.02% 824

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Acquisition's CBPO Position: Q3 2016 in Review

Emerald Acquisition reduced its China Biologic Products Holdings, Inc. (CBPO) stake by 30% in Q3 2016, selling an estimated $4.07M and leaving 82,146 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #859.

Emerald Acquisition first reported a position in CBPO in Q2 2016 and has held it in 2 quarters since. The position peaked at $12.4M in Q2 2016. 162 funds tracked by Wall St. Rank hold CBPO as of Q3 2016.

  • Emerald Acquisition held 82,146 shares of China Biologic Products Holdings, Inc. worth $10.2M as of Q3 2016.
  • Emerald Acquisition sold 34,488 China Biologic Products Holdings, Inc. shares in Q3 2016, an estimated $4.07M.
  • China Biologic Products Holdings, Inc. made up 0.02% of Emerald Acquisition's portfolio in Q3 2016, its #859 holding.
  • Emerald Acquisition first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's China Biologic Products Holdings, Inc. position peaked at $12.4M in Q2 2016.
  • 162 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.